EpiVax Launches Precision Cancer Immunotherapy Venture, EpiVax Oncology – PR Newswire (press release)
|
EpiVax Launches Precision Cancer Immunotherapy Venture, EpiVax Oncology
PR Newswire (press release) EpiVax has provided $500,000 in seed funding and has provided exclusive access to enabling technologies to the new precision immunotherapy venture. Gad Berdugo MSc Eng., MBA will lead EpiVax Oncology as Chief Executive Officer. Gad brings over 25 … |
